Aspirin therapy, as compared with placebo, significantly reduced the rate of major vascular events with improved net clinical benefit and also reduced the rate of recurrent venous thromboembolism.
Article Limit Reached
You have reached your article limit for the month. Subscribe now to access this article plus other member-only content.
- Award-winning Medical Content
- Latest Advances & Development in Medicine
- Unbiased Content